The global prevalence and association between the risk of myocarditis and mRNA-based COVID-19 vaccination: A network meta-analysis version 1; peer review: awaiting peer review

• Main Authors: Rohman, M., Fajar, J. K., Soegiarto, G., Wulandari, L., Anshory, M., Ilmawan, M., Marlysawati, D., Purnamasari, Y., Kusuma, A. P., Asmiragani, A.., Adhiatma, D., Permanasari, A.E., Pasaribu, E. A., Maliga, H. A., Pamungkas, Y., Puteri, P. W. M., Sinaga, V. A., Setiawan, D., Putri, E. N., Fattima, E. T., Prawoto, O. L., Safitri, R., Yuliana, R., Hikmah, K., Putri, Y. S., Nurzaidah, L., Lianto, L., Cahya, M. D., Ikhsan, M., Ibrahim, I., Samudra, A. D., Tamara, F., Kartini, D. A., Mahendra, A. I., Dhama, K., Harapan, H.
• Format: Article PeerReviewed
• Language: English
• Published: F1000Research 2022
• Subjects: Medical Virology
• Online Access: https://repository.ugm.ac.id/283947/1/35.pdf; https://repository.ugm.ac.id/283947/; https://f1000research.com/articles/11-862
• Institution: Universitas Gadjah Mada

Background: Cases of myocarditis development have been reported after administration of messenger ribonucleic acid (mRNA)-based coronavirus disease (COVID-19) vaccines. However, the reports vary among the studies, and the types of mRNA vaccines with potential to cause myocarditis remain unidentified...